Table of Content

1 INTRODUCTION 15
1.1 OBJECTIVES OF THE STUDY 15
1.2 MARKET DEFINITION 15
1.3 MARKET SCOPE 16
1.3.1 MARKETS COVERED 16
1.3.2 YEARS CONSIDERED FOR THE STUDY 16
1.4 CURRENCY USED FOR THE STUDY 17
1.5 MARKET STAKEHOLDERS 17

2 RESEARCH METHODOLOGY 18
2.1 RESEARCH APPROACH 18
2.1.1 SECONDARY SOURCES 19
2.1.1.1 Key data from secondary sources 19
2.1.2 PRIMARY SOURCES 20
2.1.2.1 Key data from primary sources 20
2.2 MARKET SIZE ESTIMATION 22
2.2.1 PRODUCT-BASED MARKET ESTIMATION 22
2.2.2 END USER-BASED MARKET ESTIMATION 23
2.2.3 PRIMARY RESEARCH VALIDATION 24
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 25
2.4 MARKET SHARE ESTIMATION 26
2.5 ASSUMPTIONS FOR THE STUDY 26

3 EXECUTIVE SUMMARY 27

4 PREMIUM INSIGHTS 31
4.1 ASPIRATION AND BIOPSY NEEDLES MARKET OVERVIEW 31
4.2 ASPIRATION AND BIOPSY NEEDLES MARKET SHARE, BY PRODUCT 31
4.3 ASPIRATION AND BIOPSY NEEDLES MARKET, BY END USER,
2019 VS. 2024 (USD MILLION) 32
4.4 ASPIRATION AND BIOPSY NEEDLES MARKET, BY PROCEDURE,
2019 VS. 2024 (USD MILLION) 32
4.5 ASPIRATION AND BIOPSY NEEDLES MARKET, BY SITE, 2019 VS. 2024 (USD MILLION) 33
4.6 ASPIRATION AND BIOPSY NEEDLES MARKET, BY REGION 33
?

5 MARKET OVERVIEW 34
5.1 MARKET DYNAMICS 34
5.1.1 DRIVERS 35
5.1.1.1 Rising prevalence of cancer 35
5.1.1.2 Cancer awareness initiatives undertaken by governments and global health organizations 36
5.1.1.3 Increasing preference for minimally invasive biopsies 36
5.1.2 RESTRAINTS 37
5.1.2.1 Risk of infections associated with the use of aspiration and biopsy needles 37
5.1.3 OPPORTUNITIES 37
5.1.3.1 Emerging economies 37
5.1.4 CHALLENGES 37
5.1.4.1 Underdeveloped healthcare infrastructure and dearth of well-trained radiologists and oncologists 37
5.2 INDUSTRY TRENDS 38
5.2.1 EMERGENCE OF LIQUID BIOPSY 38

6 ASPIRATION AND BIOPSY NEEDLES MARKET, BY PRODUCT 39
6.1 INTRODUCTION 40
6.2 BIOPSY NEEDLES 40
6.2.1 BIOPSY NEEDLES MARKET SPLIT, BY SITE, 2017–2024 (USD MILLION) 41
6.2.2 BIOPSY NEEDLES MARKET SPLIT, BY PROCEDURE,
2017–2024 (USD MILLION) 42
6.2.3 BIOPSY NEEDLES MARKET SPLIT, BY END USER,
2017–2024 (USD MILLION) 42
6.2.4 CNB NEEDLES 43
6.2.4.1 Low procedural costs, accuracy, and rapidity of core needle biopsy procedures will drive demand for associated needles 43
6.2.5 CNB NEEDLES MARKET SPLIT, BY SITE, 2017–2024 (USD MILLION) 44
6.2.6 CNB NEEDLES MARKET SPLIT, BY PROCEDURE, 2017–2024 (USD MILLION) 44
6.2.7 CNB NEEDLES MARKET SPLIT, BY END USER, 2017–2024 (USD MILLION) 45
6.2.8 VAB NEEDLES 45
6.2.8.1 High diagnostic specificity of vacuum-assisted biopsy is likely to drive market growth 45
6.2.9 VAB NEEDLES MARKET SPLIT, BY SITE, 2017–2024 (USD MILLION) 46
6.2.10 VAB NEEDLES MARKET SPLIT, BY PROCEDURE, 2017–2024 (USD MILLION) 47
6.2.11 VAB NEEDLES MARKET SPLIT, BY END USER, 2017–2024 (USD MILLION) 47
6.3 ASPIRATION NEEDLES 48
6.3.1 LOW ACCURACY AND THE POSSIBILITY OF FALSE-POSITIVE RESULTS HAVE HINDERED THE ADOPTION OF ASPIRATION NEEDLES 48
6.3.2 ASPIRATION NEEDLES MARKET SPLIT, BY SITE, 2017–2024 (USD MILLION) 49
6.3.3 ASPIRATION NEEDLES MARKET SPLIT, BY PROCEDURE,
2017–2024 (USD MILLION) 49
6.3.4 ASPIRATION NEEDLES MARKET SPLIT, BY END USER,
2017–2024 (USD MILLION) 50

7 ASPIRATION AND BIOPSY NEEDLES MARKET, BY PROCEDURE 51
7.1 INTRODUCTION 52
7.2 IMAGE-GUIDED PROCEDURES 53
7.2.1 ULTRASOUND 54
7.2.1.1 Ultrasound is gradually becoming the most important adjunctive imaging modality for cancer diagnosis 54
7.2.2 STEREOTACTIC 55
7.2.2.1 Stereotactic-guided biopsy can evaluate tiny masses which are not visible through ultrasound 55
7.2.3 MRI 56
7.2.3.1 High cost, limited reimbursement, and lengthy procedure?
key factors restraining the market growth 56
7.2.4 OTHER IMAGE-GUIDED PROCEDURES 57
7.3 NONIMAGE-GUIDED PROCEDURES 58
7.3.1 NONIMAGE-GUIDED PROCEDURES ARE MAJORLY PERFORMED IN SUPERFICIAL AREAS OF SUSPICIOUS ABNORMALITY 58

8 ASPIRATION AND BIOPSY NEEDLES MARKET, BY SITE 59
8.1 INTRODUCTION 60
8.2 BREAST 60
8.2.1 INCREASING AWARENESS OF BREAST CANCER TO DRIVE THE GROWTH OF THIS MARKET SEGMENT 60
8.3 LUNG 62
8.3.1 GROWING PREVALENCE OF LUNG CANCER TO SUPPORT THE GROWTH OF THIS MARKET SEGMENT 62
8.4 COLORECTAL 63
8.4.1 ADVANCEMENTS IN ALTERNATIVE DIAGNOSIS TECHNIQUES TO REDUCE THE ADOPTION OF COLORECTAL BIOPSY NEEDLES 63
8.5 PROSTATE 64
8.5.1 AVAILABILITY OF FUNDS FOR PROSTATE CANCER RESEARCH BY DIFFERENT GOVERNMENT AUTHORITIES TO SUPPORT THE GROWTH OF THIS MARKET SEGMENT 64
8.6 KIDNEY 65
8.6.1 RISING PREVALENCE OF KIDNEY CANCER TO SUPPORT THE GROWTH OF THIS MARKET SEGMENT 65
8.7 BONE AND BONE MARROW 66
8.7.1 RISING INCIDENCE OF BONE CANCER ACROSS THE GLOBE TO DRIVE THE GROWTH OF THIS MARKET SEGMENT 66
8.8 OTHER SITES 67
?

9 ASPIRATION AND BIOPSY NEEDLES MARKET, BY REGION 68
9.1 INTRODUCTION 69
9.2 NORTH AMERICA 70
9.2.1 US 74
9.2.1.1 The US dominates the North American aspiration and biopsy needles market primarily due to a large number of diagnostic imaging procedures performed in the country 74
9.2.2 CANADA 76
9.2.2.1 Rising prevalence of cancer is supporting the adoption of aspiration and biopsy needles in Canada 76
9.3 EUROPE 77
9.3.1 GERMANY 81
9.3.1.1 High healthcare spending and per capita healthcare spending in the country to support market growth 81
9.3.2 UK 82
9.3.2.1 Growing awareness and support for cancer-related activities are propelling the growth of the aspiration and biopsy needles market in the country 82
9.3.3 FRANCE 83
9.3.3.1 France to register the highest growth in the European aspiration and biopsy needles market 83
9.3.4 REST OF EUROPE 84
9.4 APAC 86
9.4.1 JAPAN 90
9.4.1.1 Presence of a well-developed healthcare system, coupled with the availability of a universal healthcare reimbursement policy, is aiding the growth of the aspiration and biopsy needles market in Japan 90
9.4.2 CHINA 91
9.4.2.1 Rising prevalence of cancer and the growing spending capacity of the middle-class population to drive the market for aspiration and biopsy needles in China 91
9.4.3 INDIA 92
9.4.3.1 Presence of a large patient population and growing access to healthcare facilities to support market growth 92
9.4.4 REST OF ASIA PACIFIC 93
9.5 REST OF WORLD (ROW) 94

10 COMPETITIVE LANDSCAPE 99
10.1 INTRODUCTION 99
10.2 MARKET RANKING ANALYSIS 99
10.3 COMPETITIVE SCENARIO 100
10.3.1 PRODUCT LAUNCHES AND APPROVALS 100
10.3.2 ACQUISITIONS 100
?
10.4 COMPETITIVE LEADERSHIP MAPPING 101
10.4.1 COMPETITIVE LEADERSHIP MAPPING: MAJOR MARKET PLAYERS (2017) 101
10.4.1.1 Visionary leaders 101
10.4.1.2 Innovators 101
10.4.1.3 Dynamic players 101
10.4.1.4 Emerging companies 102
11 COMPANY PROFILES 103
(Business Overview, Products Offered, Recent Developments, MnM View)*
11.1 ARGON MEDICAL DEVICES, INC. 103
11.2 BECTON, DICKINSON AND COMPANY (BD) 104
11.3 BOSTON SCIENTIFIC CORPORATION 106
11.4 CARDINAL HEALTH, INC. 108
11.5 CONMED CORPORATION 110
11.6 COOK GROUP INCORPORATED 112
11.7 HAKKO CO.,LTD. MEDICAL DEVICE DIVISION 114
11.8 INRAD INC. 115
11.9 MEDTRONIC, PLC 116
11.10 MERIT MEDICAL SYSTEMS 118
11.11 OLYMPUS CORPORATION 120
11.12 RANFAC CORPORATION 122
11.13 REMINGTON MEDICAL INC. 123
11.14 SOMATEX MEDICAL TECHNOLOGIES 124
11.15 STRYKER CORPORATION 125
*Business Overview, Products Offered, Recent Developments, MnM View might not be captured in case of unlisted companies.
12 APPENDIX 127
12.1 DISCUSSION GUIDE 127
12.2 KNOWLEDGE STORE: MARKETSANDMARKETS? SUBSCRIPTION PORTAL 131
12.3 AVAILABLE CUSTOMIZATIONS 133
12.4 RELATED REPORTS 133
12.5 AUTHOR DETAILS 134



List of Figures



FIGURE 1 RESEARCH DESIGN 18
FIGURE 2 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION AND REGION 21
FIGURE 3 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING 21
FIGURE 4 PRODUCT-BASED MARKET SIZE ESTIMATION: ASPIRATION AND BIOPSY NEEDLES MARKET 23
FIGURE 5 END-USER BASED ESTIMATION: ASPIRATION AND BIOPSY NEEDLES MARKET 24
FIGURE 6 ASPIRATION AND BIOPSY NEEDLES MARKET, BY PRODUCT 2019–2024 (USD MILLION) 27
FIGURE 7 ASPIRATION AND BIOPSY NEEDLES MARKET, BY SITE, 2019–2024 (USD MILLION) 28
FIGURE 8 ASPIRATION AND BIOPSY NEEDLES MARKET SHARE, BY PROCEDURE 2019 VS 2024 28
FIGURE 9 ASPIRATION AND BIOPSY NEEDLES MARKET, BY END USER 2019–2024 (USD MILLION) 29
FIGURE 10 ASPIRATION AND BIOPSY NEEDLES MARKET, BY REGION 30
FIGURE 11 RISING PREVALENCE OF CANCER GLOBALLY IS A KEY DRIVER FOR THE MARKET 31
FIGURE 12 BIOPSY NEEDLES HELD THE LARGEST SHARE OF THE MARKET IN 2018 31
FIGURE 13 HOSPITALS COMMAND THE LARGEST SHARE OF THE MARKET 32
FIGURE 14 IMAGE-GUIDANCE PROCEDURES HOLD THE LARGEST SHARE OF THE MARKET 32
FIGURE 15 BREAST PROCEDURES TO DOMINATE THE MARKET DURING
THE FORECAST PERIOD 33
FIGURE 16 APAC TO GROW AT THE HIGHEST CAGR DURING THE FORECAST PERIOD 33
FIGURE 17 ASPIRATION AND BIOPSY NEEDLES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 34
FIGURE 18 INCIDENCE OF CANCER, BY COUNTRY/REGION, 2012–2020 (THOUSAND) 35
FIGURE 19 NORTH AMERICA: ASPIRATION AND BIOPSY NEEDLES MARKET SNAPSHOT 70
FIGURE 20 EUROPE: ASPIRATION AND BIOPSY NEEDLES MARKET SNAPSHOT 77
FIGURE 21 APAC: ASPIRATION AND BIOPSY NEEDLES MARKET SNAPSHOT 86
FIGURE 22 ROW: ASPIRATION AND BIOPSY NEEDLES MARKET SNAPSHOT 95
FIGURE 23 ASPIRATION AND BIOPSY NEEDLES MARKET RANKING, BY KEY PLAYER, 2018 99
FIGURE 24 COMPETITIVE LEADERSHIP MAPPING (OVERALL MARKET) 102
FIGURE 25 BD: COMPANY SNAPSHOT 104
FIGURE 26 BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT-2018 106
FIGURE 27 CARDINAL HEALTH, INC.: COMPANY SNAPSHOT 108
FIGURE 28 CONMED CORPORATION: COMPANY SNAPSHOT 110
FIGURE 29 MEDTRONIC, PLC: COMPANY SNAPSHOT 116
FIGURE 30 MERIT MEDICAL SYSTEMS: COMPANY SNAPSHOT 118
FIGURE 31 OLYMPUS CORPORATION: COMPANY SNAPSHOT 120
FIGURE 32 STRYKER CORPORATION: COMPANY SNAPSHOT 125

 

List of Tables



TABLE 1 ASPIRATION AND BIOPSY NEEDLES MARKET, BY PRODUCT 2017–2024 (USD MILLION) 40
TABLE 2 BIOPSY NEEDLES MARKET, BY TYPE, 2017–2024 (USD MILLION) 40
TABLE 3 BIOPSY NEEDLES MARKET, BY REGION, 2017–2024 (USD MILLION) 41
TABLE 4 BIOPSY NEEDLES MARKET SPLIT , BY SITE, 2017–2024, (USD MILLION) 41
TABLE 5 BIOPSY NEEDLES MARKET SPLIT, BY PROCEDURE, 2017–2024, (USD MILLION) 42
TABLE 6 BIOPSY NEEDLES MARKET SPLIT , BY END USER, 2017–2024, (USD MILLION) 42
TABLE 7 CNB NEEDLES MARKET, BY REGION, 2017–2024 (USD MILLION) 43
TABLE 8 CNB NEEDLES MARKET, BY SITE, 2017–2024, (USD MILLION) 44
TABLE 9 CNB NEEDLES MARKET, BY PROCEDURE, 2017–2024, (USD MILLION) 44
TABLE 10 CNB NEEDLES MARKET, BY END USER, 2017–2024, (USD MILLION) 45
TABLE 11 VAB NEEDLES MARKET, BY REGION, 2017–2024 (USD MILLION) 46
TABLE 12 VAB NEEDLES MARKET, BY SITE, 2017–2024, (USD MILLION) 46
TABLE 13 VAB NEEDLES MARKET, BY PROCEDURE, 2017–2024, (USD MILLION) 47
TABLE 14 VAB NEEDLES MARKET, BY END USER, 2017–2024, (USD MILLION) 47
TABLE 15 ASPIRATION NEEDLES MARKET, BY REGION, 2017–2024 (USD MILLION) 48
TABLE 16 ASPIRATION NEEDLES MARKET, BY SITE, 2017–2024, (USD MILLION) 49
TABLE 17 ASPIRATION NEEDLES MARKET, BY PROCEDURE, 2017–2024, (USD MILLION) 49
TABLE 18 ASPIRATION NEEDLES SPLIT, BY END USER, 2017–2024, (USD MILLION) 50
TABLE 19 ASPIRATION AND BIOPSY NEEDLES MARKET, BY PROCEDURE 2017–2024 (USD MILLION) 52
TABLE 20 ASPIRATION AND BIOPSY NEEDLES MARKET FOR IMAGE-GUIDED PROCEDURES, BY TYPE, 2017–2024 (USD MILLION) 53
TABLE 21 ASPIRATION AND BIOPSY NEEDLES MARKET FOR IMAGE-GUIDED PROCEDURES, BY REGION, 2017–2024 (USD MILLION) 53
TABLE 22 ASPIRATION AND BIOPSY NEEDLES MARKET FOR ULTRASOUND PROCEDURES BY REGION, 2017–2024 (USD MILLION) 54
TABLE 23 ASPIRATION AND BIOPSY NEEDLES MARKET FOR STEREOTACTIC PROCEDURES BY REGION, 2017–2024 (USD MILLION) 55
TABLE 24 ASPIRATION AND BIOPSY NEEDLES MARKET FOR MRI PROCEDURES, BY REGION, 2017–2024 (USD MILLION) 56
TABLE 25 ASPIRATION AND BIOPSY NEEDLES MARKET FOR OTHER IMAGE-GUIDED PROCEDURES, BY REGION, 2017–2024 (USD MILLION) 57
TABLE 26 ASPIRATION AND BIOPSY NEEDLES MARKET FOR NONIMAGE-GUIDED PROCEDURES, BY REGION, 2017–2024 (USD MILLION) 58
TABLE 27 ASPIRATION AND BIOPSY NEEDLES MARKET, BY SITE, 2017–2024 (USD MILLION) 60
TABLE 28 ASPIRATION AND BIOPSY NEEDLES MARKET FOR BREAST PROCEDURES BY REGION, 2017–2024 (USD MILLION) 61
TABLE 29 ASPIRATION AND BIOPSY NEEDLES MARKET FOR LUNG PROCEDURES, BY REGION, 2017–2024 (USD MILLION) 62
TABLE 30 ASPIRATION AND BIOPSY NEEDLES MARKET FOR COLORECTAL PROCEDURES BY REGION, 2017–2024 (USD MILLION) 63
TABLE 31 ASPIRATION AND BIOPSY NEEDLES MARKET FOR PROSTATE PROCEDURES BY REGION, 2017–2024 (USD MILLION) 64
TABLE 32 ASPIRATION AND BIOPSY NEEDLES MARKET FOR KIDNEY PROCEDURES BY REGION, 2017–2024 (USD MILLION) 65
TABLE 33 ASPIRATION AND BIOPSY NEEDLES MARKET FOR BONE AND BONE MARROW PROCEDURES, BY REGION, 2017–2024 (USD MILLION) 66
TABLE 34 ASPIRATION AND BIOPSY NEEDLES MARKET FOR PROCEDURES AT OTHER SITES, BY REGION, 2017–2024 (USD MILLION) 67
TABLE 35 ASPIRATION AND BIOPSY NEEDLES MARKET, BY REGION 2017–2024 (USD MILLION) 69
TABLE 36 NORTH AMERICA: ASPIRATION AND BIOPSY NEEDLES MARKET BY COUNTRY, 2017–2024 (USD MILLION) 71
TABLE 37 NORTH AMERICA: ASPIRATION AND BIOPSY NEEDLES MARKET BY PRODUCT, 2017–2024 (USD MILLION) 71
TABLE 38 NORTH AMERICA: BIOPSY NEEDLES MARKET, BY PRODUCT TYPE 2017–2024 (USD MILLION) 72
TABLE 39 NORTH AMERICA: ASPIRATION AND BIOPSY NEEDLES MARKET, BY SITE 2017–2024 (USD MILLION) 72
TABLE 40 NORTH AMERICA: ASPIRATION AND BIOPSY NEEDLES MARKET, BY PROCEDURE, 2017–2024 (USD MILLION) 73
TABLE 41 NORTH AMERICA: ASPIRATION AND BIOPSY NEEDLES MARKET FOR IMAGE-GUIDED PROCEDURE, BY TYPE, 2017–2024 (USD MILLION) 73
TABLE 42 NORTH AMERICA: ASPIRATION AND BIOPSY NEEDLES MARKET, BY END USER, 2017–2024 (USD MILLION) 74
TABLE 43 ESTIMATED NEW CASES OF CANCER IN 2019 74
TABLE 44 US: ASPIRATION AND BIOPSY NEEDLES MARKET, BY PRODUCT 2017–2024 (USD MILLION) 75
TABLE 45 CANADA: ASPIRATION AND BIOPSY NEEDLES MARKET, BY PRODUCT 2017–2024 (USD MILLION) 76
TABLE 46 EUROPE: ASPIRATION AND BIOPSY NEEDLES MARKET, BY COUNTRY 2017–2024 (USD MILLION) 78
TABLE 47 EUROPE: ASPIRATION AND BIOPSY NEEDLES MARKET, BY PRODUCT 2017–2024 (USD MILLION) 78
TABLE 48 EUROPE: BIOPSY NEEDLES MARKET, BY PRODUCT TYPE 2017–2024 (USD MILLION) 79
TABLE 49 EUROPE: ASPIRATION AND BIOPSY NEEDLES MARKET, BY SITE 2017–2024 (USD MILLION) 79
TABLE 50 EUROPE: ASPIRATION AND BIOPSY NEEDLES MARKET, BY PROCEDURE 2017–2024 (USD MILLION) 80
TABLE 51 EUROPE: ASPIRATION AND BIOPSY NEEDLES MARKET FOR IMAGE-GUIDED PROCEDURE, BY TYPE, 2017–2024 (USD MILLION) 80
TABLE 52 EUROPE: ASPIRATION AND BIOPSY NEEDLES MARKET, BY END USER 2017–2024 (USD MILLION) 81
TABLE 53 GERMANY: ASPIRATION AND BIOPSY NEEDLES MARKET, BY PRODUCT 2017–2024 (USD MILLION) 82
TABLE 54 UK: ASPIRATION AND BIOPSY NEEDLES MARKET, BY PRODUCT 2017–2024 (USD MILLION) 83
TABLE 55 FRANCE: ASPIRATION AND BIOPSY NEEDLES MARKET, BY PRODUCT 2017–2024 (USD MILLION) 84
TABLE 56 ROE: ASPIRATION AND BIOPSY NEEDLES MARKET, BY PRODUCT 2017–2024 (USD MILLION) 85
TABLE 57 APAC: ASPIRATION AND BIOPSY NEEDLES MARKET, BY COUNTRY 2017–2024 (USD MILLION) 87
TABLE 58 APAC: ASPIRATION AND BIOPSY NEEDLES MARKET, BY PRODUCT 2017–2024 (USD MILLION) 87
TABLE 59 APAC: BIOPSY NEEDLES MARKET, BY PRODUCT TYPE, 2017–2024 (USD MILLION) 88
TABLE 60 APAC: ASPIRATION AND BIOPSY NEEDLES MARKET, BY SITE 2017–2024 (USD MILLION) 88
TABLE 61 APAC: ASPIRATION AND BIOPSY NEEDLES MARKET, BY PROCEDURE 2017–2024 (USD MILLION) 89
TABLE 62 APAC: ASPIRATION AND BIOPSY NEEDLES MARKET FOR IMAGE-GUIDED PROCEDURE, BY TYPE, 2017–2024 (USD MILLION) 89
TABLE 63 APAC: ASPIRATION AND BIOPSY NEEDLES MARKET, BY END USER 2017–2024 (USD MILLION) 90
TABLE 64 JAPAN: ASPIRATION AND BIOPSY NEEDLES MARKET, BY PRODUCT 2017–2024 (USD MILLION) 91
TABLE 65 CHINA: ASPIRATION AND BIOPSY NEEDLES MARKET, BY PRODUCT 2017–2024 (USD MILLION) 92
TABLE 66 INDIA: ASPIRATION AND BIOPSY NEEDLES MARKET, BY PRODUCT 2017–2024 (USD MILLION) 93
TABLE 67 ROAPAC: ASPIRATION AND BIOPSY NEEDLES MARKET, BY PRODUCT 2017–2024 (USD MILLION) 94
TABLE 68 ROW: ASPIRATION AND BIOPSY NEEDLES MARKET, BY PRODUCT 2017–2024 (USD MILLION) 95
TABLE 69 ROW: BIOPSY NEEDLES MARKET, BY PRODUCT TYPE, 2017–2024 (USD MILLION) 96
TABLE 70 ROW: ASPIRATION AND BIOPSY NEEDLES MARKET, BY SITE 2017–2024 (USD MILLION) 96
TABLE 71 ROW: ASPIRATION AND BIOPSY NEEDLES MARKET, BY PROCEDURE 2017–2024 (USD MILLION) 97
TABLE 72 ROW: ASPIRATION AND BIOPSY NEEDLES MARKET FOR IMAGE-GUIDED PROCEDURE, BY TYPE, 2017–2024 (USD MILLION) 97
TABLE 73 ROW: ASPIRATION AND BIOPSY NEEDLES MARKET, BY END USER 2017–2024 (USD MILLION) 98
TABLE 74 PRODUCT LAUNCHES AND APPROVALS 100